 Opposing Views | Anthera prepares for late-stage lupus drug trials Businessweek The company plans to run two 52-week trials that compare blisibimod to placebo in patients who have systemic lupus and whose symptoms are not fully controlled despite treatment with corticosteroids. The Hayward, Calif., company's shares jumped 12 cents ... Anthera Announces the Advancement of Blisibimod into Phase 3 Development ... |
